Stay updated on Iberdomide vs Lenalidomide Maintenance in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide vs Lenalidomide Maintenance in Myeloma Clinical Trial page.

Latest updates to the Iberdomide vs Lenalidomide Maintenance in Myeloma Clinical Trial page
- Check7 days agoChange DetectedVersion 63 was added (dated 2026-02-16), updating the Study Status and Contacts/Locations sections of the record history. A deletion dated 2026-02-10 was also recorded.SummaryDifference0.2%

- Check14 days agoChange DetectedNewest version adds Contacts/Locations and Study Status sections (v3.4.2) to the record, enhancing access to site contacts and current recruitment status. The outdated funding-operation notice was removed.SummaryDifference0.6%

- Check21 days agoChange DetectedThe page now displays a top government-funding notice and a new revision entry (v3.4.1, 2026-02-02) with added IPDSharing, Contacts/Locations, and Study Status; the previous revision (v3.4.0, 2026-01-13) was removed.SummaryDifference0.7%

- Check28 days agoChange DetectedShow glossary option added and color-coding explanations introduced to clarify how changes are displayed. Removal of 'No FEAR Act data' and update of the revision label from v3.3.4 to v3.4.0.SummaryDifference0.5%

- Check57 days agoChange DetectedDifference0.3%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 to the history; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

Stay in the know with updates to Iberdomide vs Lenalidomide Maintenance in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide vs Lenalidomide Maintenance in Myeloma Clinical Trial page.